A huge announcement has recently been published hot off the White House press which is the Obama Administration will be making a major reduction on restrictions that have delayed the government’s process on marijuana research policy.
Up until now, all cannabis research that is not paid for by the government must go through a Public Health Service review, a necessity that applies to marijuana research only; no other controlled substances classified as a Schedule 1 under the Controlled Substance Act are subject to the same process. As a result, the review process has been criticized by lawmakers and researchers alike.
The Public Service Health review was created in 1999 to ensure that all research was scientifically valid, yet more times than not has created a barrier for new studies. One must submit the scientific proposal to the Food and Drug Administration and obtain approval based off of the “scientific validity and ethical soundness” of the project. After jumping this obstacle the research must also be approved by the Public Health Service board, and the only then would the people conducting the study be granted a cannabis permit from the Drug Enforcement Administration and receive a piece of government cultivated marijuana from the National Institute on Drug Abuse, which controls the only legal, federally cultivated marijuana in the US for research reasons.
With backing from the Obama Administration, lifting the bureaucratic red tape will let studies conducted on cannabis a much greater level of freedom and allow the research parameters to grow and include positive advantages of marijuana, instead of concerning their efforts on harmful effects.
A statement from the Office of National Drug Control Policy spokesman Mario Moreno Zepeda affirmed this result, stating: “The Obama Administration has actively supported scientific research on whether marijuana or its components can be safe and effective medicine. Eliminating the Public Health Service review should help facilitate additional research to advance our understanding of both the adverse effects and potential therapeutic uses for marijuana or its components.”
This measure indicates a crucial change in the political stance and regard for marijuana and it uses, and should open the window to not just new and groundbreaking marijuana research, but potentially could lead to a switch in federal drug policy.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
1 comment
What about hemp? Yahoo for marijuana and its THC…. but how about relaxing the growing, etc. rules for hemp? After all, there are CBDs in hemp besides all the other uses for this plant. Idiotic to relax rules on marijuana and keep them tough on hemp. MORONIC, actually.